Prader—Willi syndrome and the hypothalamus
暂无分享,去创建一个
[1] B. Bloch,et al. Comparative immunohistochemical study of the distribution of neuropeptide Y, growth hormone-releasing factor and the carboxyterminus of precursor protein GHRF in the human hypothalamic infundibular area. , 1990, Neuroendocrinology.
[2] S. Leibowitz,et al. Hypothalamic paraventricular nucleus lesions produce overeating and obesity in the rat , 1981, Physiology & Behavior.
[3] D. Swaab,et al. THE INFLUENCE OF ANENCEPHALY UPON INTRAUTERINE GROWTH OF FETUS AND PLACENTA AND UPON GESTATION LENGTH , 1973, The Journal of obstetrics and gynaecology of the British Commonwealth.
[4] R. Wharton,et al. NEONATAL RESPIRATORY DEPRESSION AND DELAY IN DIAGNOSIS IN PRADER‐WILLI SYNDROME , 1989, Developmental medicine and child neurology.
[5] R. Scully,et al. Hypogonadotropinism in Prader-Willi syndrome. Induction of puberty and sperm altogenesis by clomiphene citrate. , 1972, The American journal of medicine.
[6] D. Swaab,et al. Circulating neurohypophyseal hormones in anencephalic infants. , 1987, American journal of obstetrics and gynecology.
[7] D. Swaab,et al. Vasopressin and oxytocin: distribution and putative functions in the brain. , 1983, Progress in brain research.
[8] D. Swaab,et al. The influence of the fetal hypothalamus and pituitary on the onset and course of parturition. , 1977, Ciba Foundation symposium.
[9] E. Ghigo,et al. Growth hormone (GH) response to combined pyridostigmine and GH-releasing hormone administration in patients with Prader-Labhard-Willi syndrome. , 1993, Hormone research.
[10] R. Ruvalcaba,et al. Hypogonadism in Prader-Willi syndrome. , 1975, American journal of mental deficiency.
[11] J. Parkes,et al. Sleep apnoea in the Prader‐Willi syndrome , 1994, Journal of sleep research.
[12] A. Prader. Ein Syndrom von Adipositas, Kleinwuchs, Kryptorchismus und Oligophrenie nach myatonieartigem Zustand im Neugeborenenalter. , 1956 .
[13] E. Stricker,et al. Brain oxytocin receptor antagonism blunts the effects of anorexigenic treatments in rats: evidence for central oxytocin inhibition of food intake. , 1991, Endocrinology.
[14] P. Fredrickson,et al. Sleep and breathing in patients with the Prader-Willi syndrome. , 1991, Mayo Clinic proceedings.
[15] M. Sarrantonio,et al. Growth Hormone Secretion and Effects of Growth Hormone Therapy on Growth Velocity and Weight Gain in Children with Prader-Willi Syndrome , 1996, Journal of pediatric endocrinology & metabolism : JPEM.
[16] V. A. Holm,et al. Growth Hormone Secretion in Prader‐Willi Syndrome , 1990, Acta paediatrica Scandinavica.
[17] D. Swaab,et al. Differential expression of the neuroendocrine polypeptide 7B2 in hypothalami of Prader-(Labhart)-Willi syndrome patients , 1994, Brain Research.
[18] D. Swaab,et al. Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases. , 1995, The Journal of clinical endocrinology and metabolism.
[19] E. Stricker,et al. Oxytocin and an oxytocin agonist administered centrally decrease food intake in rats , 1991, Peptides.
[20] M. Castro-Magana,,et al. Pituitary Evaluation and Growth Hormone Treatment in Prader-Willi Syndrome , 1991 .
[21] A. Kales,et al. Sleep in the Prader-Willi syndrome. Clinical and polygraphic findings. , 1984, Archives of neurology.
[22] A. Benelli,et al. Oxytocin-induced inhibition of feeding and drinking: No sexual dimorphism in rats , 1991, Neuropeptides.
[23] D. Swaab,et al. Life span changes in the presence of alpha-melanocyte-stimulating-hormone-containing cells in the human pituitary. , 1979, Journal of developmental physiology.
[24] Darrell M. Wilson,et al. Growth hormone treatment of short stature in Prader-Willi syndrome , 1986 .
[25] R. Rogers,et al. Oxytocin, oxytocin antagonist, TRH, and hypothalamic paraventricular nucleus stimulation effects on gastric motility , 1987, Peptides.